Impax Laboratories Appoints New Board Member
This article was originally published in Scrip
Executive Summary
Impax Laboratories has appointed Janet S. Vergis to its board of directors – effective Oct.7, 2015. Since 2013, Vergis has been executive advisor for private equity firms and is currently at Water Street Healthcare Partners, LLC. and Deerfield Management. Previously she was an executive in residence advisor at Warburg Pincus, LLC. Prior to her advisory roles, Vergis was CEO of OraPharma, Inc. and before that she held various executive leadership roles at Johnson & Johnson and its subsidiaries, including Janssen Pharmaceuticals, McNeil Pediatrics and Ortho-McNeil Neurologics, where she was president.